Beta blockers cause cold hands and feet by reducing blood flow to your extremities. They do this through two connected mechanisms: blocking receptors in your blood vessels that normally help them stay open, and lowering the overall output of your heart. About 7% of people taking beta blockers experience this side effect, though some studies in smaller groups have found rates as high as 50%.
How Beta Blockers Restrict Blood Flow
Your blood vessels have receptors on their walls called beta-2 receptors. When these receptors are activated, they signal the vessel to relax and widen, allowing more blood through. This is especially important in the small vessels of your fingers and toes, where blood flow is already modest compared to your core organs.
Beta blockers, particularly non-selective types, block these beta-2 receptors along with the beta-1 receptors in your heart (which is their intended target). With the beta-2 receptors blocked, your peripheral blood vessels lose one of their key signals to stay dilated. The result is narrower vessels and less warm blood reaching your hands and feet. At the same time, your body’s natural vessel-constricting signals, driven by adrenaline acting on alpha receptors, go unopposed. The balance tips toward constriction.
There’s also a second, more indirect mechanism. Beta blockers slow your heart rate and reduce how forcefully your heart contracts. This lowers your total cardiac output, the volume of blood your heart pumps per minute. When less blood is circulating overall, your body prioritizes vital organs. Your extremities are the first to get shortchanged, since your circulatory system treats them as low priority when supply is limited.
Not All Beta Blockers Are Equal
The severity of this side effect depends heavily on which beta blocker you’re taking. Non-selective beta blockers block both beta-1 receptors (in the heart) and beta-2 receptors (in blood vessels). These are more likely to cause cold extremities because they directly interfere with the vasodilation signal in peripheral vessels.
Cardioselective (beta-1 selective) beta blockers primarily target the heart and leave beta-2 receptors in the blood vessels relatively untouched. As the American Heart Association has noted, there is less reflex vasoconstriction with beta-1 selective agents because the unblocked beta-2 receptors can still mediate vasodilation. In practice, switching from a non-selective to a beta-1 selective beta blocker often reduces cold extremities. Some beta blockers also have a property called intrinsic sympathomimetic activity, meaning they partially stimulate the receptors they block, which can further reduce this side effect.
How Common Cold Extremities Actually Are
A large systematic review covering over 28,000 patients on beta blockers found that 7% experienced peripheral vasoconstriction (cold extremities or Raynaud’s-like symptoms), compared to 4.6% on placebo. That gap confirms the effect is real but also shows it’s not universal. Some people are more susceptible based on their baseline circulation, the specific drug they take, and the dose.
Smaller, older studies have found much higher rates. One study of hypertensive patients reported that 50% of those on beta blockers had cold hands and feet, compared to just 1 out of 21 patients on an alternative blood pressure medication. The wide range in reported rates likely reflects differences in how coldness was measured, which beta blockers were used, and whether patients were specifically asked about the symptom or volunteered it.
Raynaud’s Phenomenon and Beta Blockers
For people who already have Raynaud’s phenomenon, where fingers or toes turn white or blue in response to cold or stress, beta blockers have long been considered risky. The concern is logical: if your blood vessels are already prone to spasm, blocking their ability to dilate could make episodes worse or more frequent.
The actual clinical picture is less clear-cut than you might expect. A recent Mendelian randomization study found no association between genetically modeled beta-1 receptor blockade and the risk of developing Raynaud’s. This suggests that the heart-targeted action of beta blockers may not be the problem, and that beta-2 blockade (the vessel effect) is what drives the issue. If you have Raynaud’s, the type of beta blocker matters more than whether you take one at all, though this remains an active area of clinical discussion.
What You Can Do About It
Cold hands and feet from beta blockers can range from a mild nuisance to genuinely uncomfortable, especially in colder months. Several practical strategies help.
Lowering the dose often reduces the symptom, since the degree of receptor blockade is dose-dependent. If that’s not an option, switching to a beta-1 selective beta blocker can preserve the cardiac benefits while easing peripheral constriction. Your prescriber may also consider a beta blocker with intrinsic sympathomimetic activity, which partially stimulates blood vessel receptors even as it blocks heart receptors.
On the lifestyle side, layering with warm gloves and thick socks makes a straightforward difference. Regular physical activity improves peripheral circulation over time and can partially offset the reduced cardiac output. Avoiding caffeine and nicotine helps too, since both promote additional vasoconstriction on top of what the medication is already doing.
When a Different Medication Class Makes Sense
If cold extremities are persistent and bothersome despite adjustments, other blood pressure or heart medications work through entirely different pathways that don’t restrict peripheral blood flow. ACE inhibitors and ARBs lower blood pressure by widening blood vessels rather than constricting them. Calcium channel blockers actively relax blood vessel walls. Vasodilators like hydralazine directly open arteries and improve blood flow to the extremities. None of these classes carry the same risk of cold hands and feet, and for many conditions, they’re equally effective alternatives.